InvestorsHub Logo
Followers 0
Posts 94
Boards Moderated 0
Alias Born 09/15/2009

Re: TheDane post# 1896

Friday, 10/16/2009 5:28:02 PM

Friday, October 16, 2009 5:28:02 PM

Post# of 43803
you 2 are funny,
since PFE-WYE/AMGEN own Enbrel it is either them for a replacement or one of the other 10 who want a competitor drug.
and George is right Enbrel does have a problem that Cel-2000 appears not to have. That is why the synergy between H1N1 and the Arthritis is so significant. Man if this is what it appears then absent Multikline we could all be rich along with Dr. Zimmerman

Look CVM is a 285 M cap company

Enbrel is 2 Billion a year
H1N1 is 1.5 billion a year so.

Without multikline or any cancer component CVM could gain 10X in revenue in short order. That would make me very happy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News